Efficacy of adjuvant intralesional rituximab in patients with pemphigus vulgaris and oral lesions receiving systemic rituximab: A randomized controlled pilot trial
Efficacy of adjuvant intralesional rituximab in patients with pemphigus vulgaris and oral lesions receiving systemic rituximab: A randomized controlled pilot trial. // Medicina Clínica. – URL: https://www.sciencedirect.com/science/article/pii/S0025775326003131?dgcid=rss_sd_all
Efficacy of adjuvant intralesional rituximab in patients with pemphigus vulgaris and oral lesions receiving systemic rituximab: A randomized controlled pilot trial. Medicina Clínica. https://www.sciencedirect.com/science/article/pii/S0025775326003131?dgcid=rss_sd_all
“Efficacy of adjuvant intralesional rituximab in patients with pemphigus vulgaris and oral lesions receiving systemic rituximab: A randomized controlled pilot trial.” Medicina Clínica.
@article{article117346,
title = {Efficacy of adjuvant intralesional rituximab in patients with pemphigus vulgaris and oral lesions receiving systemic rituximab: A randomized controlled pilot trial},
journal = {Medicina Clínica},
url = {https://www.sciencedirect.com/science/article/pii/S0025775326003131?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...